New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program
SAN ANTONIO, May 10, 2012 /PRNewswire-iReach/ — Electrochemical Oxygen Concepts (EO2(TM) Concepts), the developer of a unique and innovative chronic wound treatment device, announced it has been added to Marathon Medical’s (Commerce City, CO) existing Federal Supply Schedule (FSS) contract, administered by The Department of Veterans Affairs (VA). The TransCu O2(®), a noninvasive, electrochemical low-dose tissue oxygenation system for the treatment of difficult-to-heal wounds, is now available to all organizations that purchase from the FSS including the entire federal healthcare system, the largest healthcare provider in the United States with more than 1,300 Veterans health facilities, Department of Defense medical treatment facilities, Military Hospitals, and Indian Health Service Hospitals.
EO2(TM) Concepts is a privately held, advanced wound care technology company whose flagship product, the TransCu O2(®), is an FDA cleared Class III medical device. The company’s President Joe Moffett says that he believes the TransCu O2(®) can revolutionize the treatment of chronic and difficult-to-heal wounds for veterans and others who suffer from these painful and costly wounds.
“Our team is honored to partner with the Department of Veterans Affairs to provide a state-of-the-art wound care therapy for our country’s military veterans,” said Moffett. “The portable treatment is simple, can be delivered in the home environment and supports a more normal quality of life – even while receiving the treatment. We believe that the TransCu O2(® )will transform the current treatment of wound care and make a contribution to lowering costs within our healthcare system.”
The TransCu O2(® )is a simple-to-use and easy-to-administer therapy that provides a continuous supply of low-flow pure oxygen to treat a variety of lower limb wound types such as venous leg ulcers, diabetic foot ulcers, and pressure ulcers. Oxygen-based therapies have been proven effective in treating chronic wounds, yet current therapeutic approaches do not allow for 24-hour a day wound treatment. The TransCu O2(® )device is lightweight and fully portable. Its advanced technology allows for the constant monitoring with automatic flow adjustments necessary for the delivery of optimum therapeutic oxygen flow to the wound site.
Chronic lower limb wounds are a complex problem and a leading cause of disability. These wounds impact overall disease burden, quality of life, activities of daily living, and healthcare costs for thousands of Veterans. The Continuous Diffusion of Oxygen therapy provided by the TransCu O2 has demonstrated improved patient outcomes with shorter healing times while bettering the patient’s quality of life. These advanced medical outcomes can subsequently lower costs to treat difficult-to-heal wounds.
About Marathon Medical:
Marathon Medical is dedicated to providing the highest quality products and services at competitive prices creating the best value for its customers. They serve the healthcare industry nationwide with products and services that help hospitals and pharmacies reduce costs, improve productivity and deliver better care to patients. Marathon Medical salutes the contracting officers, administration personnel, nurses and doctors who take care of this nation’s heroes. They work diligently in concert with the contracting officers to combine excellent products with competitive pricing to bring the greatest value to the veteran patient.
About Electrochemical Oxygen Concepts (EO2(TM) Concepts):
EO2(TM) Concepts is a privately held advanced wound care technology company and the developer of an innovative FDA cleared Class III medical device that provides therapy to difficult-to-heal wounds. The TransCu O2(®) is an electrochemical low-dose tissue oxygenation and wound monitoring system designed for use with advanced wound dressings as an adjunctive therapy to treat oxygen compromised wounds. For more information, please visit www.eo2concepts.com.
Media Contact: Megan Augustine Megan Augustine, 210-296-9520, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Electrochemical Oxygen Concepts